Search

everythinglearnresearchcommunity

for

Search:↓

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Finasteride treatment changes Cx43 in rat testes, possibly causing fertility issues.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

A new gene, JMJD1C, may affect testosterone levels in men.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Finasteride reduces hair growth and is safe for women with excessive hair.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Finasteride exposure harms tadpole reproduction and hormone balance.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Hair transplantation techniques have improved over time, leading to natural-looking results and high graft survival rates, making it a popular treatment for hair loss.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Androgens can cause hair growth in some areas and hair loss on the scalp.